Ali, Dina <br/><br/>
APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.  [electronic resource] 

 -  European journal of haematology  Mar 2011 
 - 206-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2010.01557.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Aza Compounds--administration & dosage<br/>Base Sequence<br/>Bridged Bicyclo Compounds, Heterocyclic--administration & dosage<br/>Cytarabine--administration & dosage<br/>DNA Primers--genetics<br/>Daunorubicin--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Female<br/>Gene Expression--drug effects<br/>Genes, p53<br/>Humans<br/>Karyotyping<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Mutation<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p14ARF--metabolism<br/>Vidarabine--administration & dosage<br/>bcl-2-Associated X Protein--metabolism